» Articles » PMID: 28502444

Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications

Overview
Specialty Pediatrics
Date 2017 May 16
PMID 28502444
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome and has become the most common form of chronic liver disease in children and adolescents. The histologic spectrum of NAFLD is broad ranging, from the relatively benign form of simple steatosis to the aggressive form of nonalcoholic steatohepatitis, eventually leading to fibrosis and cirrhosis. NAFLD has also been recognized as an independent risk factor for extrahepatic complications, such as cardiovascular disease, type 2 diabetes mellitus, sleep disorders, and osteoporosis. In this review, we discuss both the hepatic and extrahepatic complications of NAFLD in children.

Citing Articles

Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China.

Wang J, Zhuang P, Lin B, Zheng J, Li H, Tang W Front Microbiol. 2025; 15:1503302.

PMID: 39764447 PMC: 11701008. DOI: 10.3389/fmicb.2024.1503302.


Integrating Multi-Omics with environmental data for precision health: A novel analytic framework and case study on prenatal mercury induced childhood fatty liver disease.

Goodrich J, Wang H, Jia Q, Stratakis N, Zhao Y, Maitre L Environ Int. 2024; 190:108930.

PMID: 39128376 PMC: 11620538. DOI: 10.1016/j.envint.2024.108930.


Effects of a High-Fat Diet and Docosahexaenoic Acid during Pregnancy on Fatty Acid Composition in the Fetal Livers of Mice.

Alvarez D, Ortiz M, Valdebenito G, Crisosto N, Echiburu B, Valenzuela R Nutrients. 2023; 15(21).

PMID: 37960348 PMC: 10649644. DOI: 10.3390/nu15214696.


Lifestyle interventions in nonalcoholic fatty liver disease.

Younossi Z, Zelber-Sagi S, Henry L, Gerber L Nat Rev Gastroenterol Hepatol. 2023; 20(11):708-722.

PMID: 37402873 DOI: 10.1038/s41575-023-00800-4.


Liver Steatosis: A Marker of Metabolic Risk in Children.

Neri C, Scapaticci S, Chiarelli F, Giannini C Int J Mol Sci. 2022; 23(9).

PMID: 35563210 PMC: 9100068. DOI: 10.3390/ijms23094822.